These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8179790)

  • 41. The relationship between age and venous plasma concentrations of noradrenaline, catecholamine metabolites, DOPA and neuropeptide Y-like immunoreactivity in normal human subjects.
    Hetland ML; Eldrup E; Bratholm P; Christensen NJ
    Scand J Clin Lab Invest; 1991 May; 51(3):219-24. PubMed ID: 1909048
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiovascular autonomic reactivity in schizophrenics under neuroleptic treatment: A potential predictor of short-term outcome?
    Agelink MW; Malessa R; Kamcili E; Zeit T; Lemmer W; Bertling R; Klieser E
    Neuropsychobiology; 1998; 38(1):19-24. PubMed ID: 9701718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Some methodological considerations for the clinical evaluation of neuroleptics--comparative effects of clozapine and haloperidol on schizophrenics.
    Itoh H; Miura S; Yagi G; Sakurai S; Ohtsuka N
    Folia Psychiatr Neurol Jpn; 1977; 31(1):17-24. PubMed ID: 863344
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clozapine response and plasma catecholamines and their metabolites.
    Green AI; Alam MY; Sobieraj JT; Pappalardo KM; Waternaux C; Salzman C; Schatzberg AF; Schildkraut JJ
    Psychiatry Res; 1993 Feb; 46(2):139-49. PubMed ID: 8483973
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma dihydroxyphenylalanine and total body and regional noradrenergic activity in humans.
    Eisenhofer G; Brush JE; Cannon RO; Stull R; Kopin IJ; Goldstein DS
    J Clin Endocrinol Metab; 1989 Feb; 68(2):247-55. PubMed ID: 2563731
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns.
    Breier A; Buchanan RW; Irish D; Carpenter WT
    Hosp Community Psychiatry; 1993 Dec; 44(12):1145-9. PubMed ID: 8132186
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task.
    Cohen RM; Nordahl TE; Semple WE; Andreason P; Litman RE; Pickar D
    Arch Gen Psychiatry; 1997 May; 54(5):481-6. PubMed ID: 9152102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of tyrosine and tryptophan ingestion on plasma catecholamine and 3,4-dihydroxyphenylacetic acid concentrations.
    Rasmussen DD; Ishizuka B; Quigley ME; Yen SS
    J Clin Endocrinol Metab; 1983 Oct; 57(4):760-3. PubMed ID: 6885965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of a peripherally acting alpha 2-adrenoceptor antagonist (L-659,066) on hemodynamics and plasma levels of catechols in conscious rats.
    Szemeredi K; Stull R; Kopin IJ; Goldstein DS
    Eur J Pharmacol; 1989 Oct; 170(1-2):53-9. PubMed ID: 2575527
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine.
    Spivak B; Roitman S; Vered Y; Mester R; Graff E; Talmon Y; Guy N; Gonen N; Weizman A
    Clin Neuropharmacol; 1998; 21(4):245-50. PubMed ID: 9704166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of clozapine on sleep measures and sleep-associated changes in growth hormone and cortisol in patients with schizophrenia.
    Lee JH; Woo JI; Meltzer HY
    Psychiatry Res; 2001 Sep; 103(2-3):157-66. PubMed ID: 11549404
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Schizophrenic patients who develop postoperative confusion have an increased norepinephrine and cortisol response to surgery.
    Kudoh A; Takahira Y; Katagai H; Takazawa T
    Neuropsychobiology; 2002; 46(1):7-12. PubMed ID: 12207140
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma sulfoconjugated dopamine levels are normal in patients with autonomic failure.
    Yamamoto T; Polinsky RJ; Goldstein DS; Baucom CE; Kopin IJ
    J Lab Clin Med; 1996 Nov; 128(5):488-91. PubMed ID: 8900291
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Weight and blood pressure change during clozapine treatment.
    Baymiller SP; Ball P; McMahon RP; Buchanan RW
    Clin Neuropharmacol; 2002; 25(4):202-6. PubMed ID: 12151907
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relative efficiencies of plasma catechol levels and ratios for neonatal diagnosis of menkes disease.
    Goldstein DS; Holmes CS; Kaler SG
    Neurochem Res; 2009 Aug; 34(8):1464-8. PubMed ID: 19234788
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Locus coeruleus norepinephrine-containing neurons: effects produced by acute and subchronic treatment with antipsychotic drugs and amphetamine.
    Ramirez OA; Wang RY
    Brain Res; 1986 Jan; 362(1):165-70. PubMed ID: 2867813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease.
    Raskind MA; Peskind ER; Holmes C; Goldstein DS
    Biol Psychiatry; 1999 Sep; 46(6):756-65. PubMed ID: 10494443
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance.
    Buchanan RW; Holstein C; Breier A
    Biol Psychiatry; 1994 Dec; 36(11):717-25. PubMed ID: 7858067
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of pharmacological doses of 2-deoxyglucose on plasma catecholamines and glucose levels in patients with schizophrenia.
    Elman I; Rott D; Green AI; Langleben DD; Lukas SE; Goldstein DS; Breier A
    Psychopharmacology (Berl); 2004 Nov; 176(3-4):369-75. PubMed ID: 15179540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia.
    Meltzer HY
    Psychopharmacology (Berl); 1989; 99 Suppl():S18-27. PubMed ID: 2682729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.